1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Dynavax Acquires Symphony Dynamo

M&A Deal Summary

Dynavax Acquires Symphony Dynamo

On December 30, 2009, Dynavax acquired life science company Symphony Dynamo

Acquisition Highlights
  • This is Dynavax’s 1st transaction in the Life Science sector.
  • This is Dynavax’s 1st transaction in the United States.
  • This is Dynavax’s 1st transaction in Maryland.

M&A Deal Summary
Date 2009-12-30
Target Symphony Dynamo
Sector Life Science
Buyer(s) Dynavax
Deal Type Add-on Acquisition

Target

Symphony Dynamo

Rockville, Maryland, United States
Symphony Dynamo, Inc. engages in the clinical development of therapeutics to treat hepatitis B, hepatitis C, and cancer.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Dynavax

EmeryVille, California, United States
Category Company
Founded 1996
Sector Life Science
Employees405
Revenue 277M USD (2024)
DESCRIPTION

Dynavax is a bio-pharmaceutical company that develops products to treat allergy, inflammation-mediated diseases, infectious diseases and cancer. Dynavax's lead products are based on ImmunoStimulatory Sequences (ISS), short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Dynavax was founded in 1996 and is based in Emeryville, California.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Maryland M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2009 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal